Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
BMJ Case Rep ; 20132013 Feb 18.
Article in English | MEDLINE | ID: mdl-23420730

ABSTRACT

A 68-year-old man presented to the accident and emergency department with a history of central chest pain associated with exertion. He was admitted for assessment and when an acute coronary syndrome was excluded, he underwent exercise stress testing. His exercise stress testing was discontinued due to lightheadedness. His capillary glucose was checked and it showed hypoglycaemia (2.2 mmol/l). In light of this, a 72 h supervised fast was performed and it became positive within 24 h with low plasma glucose, inappropriately high insulin and C peptide levels. Sulfonylurea screen was negative. CT, MRI and endoscopic ultrasound revealed a 2 cm pancreatic tail insulinoma. He underwent successful surgical enucleation of this lesion.


Subject(s)
Exercise Test/adverse effects , Hypoglycemia/etiology , Insulinoma/diagnosis , Pancreatic Neoplasms/diagnosis , Aged , Blood Glucose/analysis , C-Peptide/blood , Humans , Insulin/blood , Insulinoma/complications , Male , Pancreatic Neoplasms/complications
2.
Exp Physiol ; 93(9): 1058-64, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18487313

ABSTRACT

This study aimed to quantify the effect of cardiac hypertrophy induced with isoprenaline and caffeine on reflex regulation of renal sympathetic nerve activity by the arterial and cardiopulmonary baroreceptors. Male Wistar rats, untreated or given water containing caffeine and subcutaneous (s.c.) isoprenaline every 72 h for 2 weeks or thyroxine s.c. for 7 days, were anaesthetized and prepared for measurement of renal sympathetic nerve activity or cardiac indices. Both isoprenaline-caffeine and thyroxine treatment blunted weight gain but increased heart weight and heart weight to body weight ratio by 40 and 14% (both P<0.01), respectively. In the isoprenaline-caffeine group, the maximal rate of change of left ventricular pressure and the contractility index were higher by 17 and 14% (both P<0.01), respectively, compared with untreated rats. In the isoprenaline-caffeine-treated rats, baroreflex gain curve sensitivity was depressed by approximately 30% (P<0/05), while the mid-point blood pressure was lower, by 15% (P<0/05), and the range of the curve was 60% (P<0.05) greater than in the untreated rats. An acute intravenous infusion of a saline load decreased renal sympathetic nerve activity by 42% (P<0.05) in the untreated rats but had no effect in the isoprenaline-caffeine- or the thyroxine-treated groups. The isoprenaline-caffeine treatment induced cardiac hypertrophy with raised cardiac performance and an associated depression in the reflex regulation of renal sympathetic nerve activity by both high- and low-pressure baroreceptors. The thyroxine-induced cardiac hypertrophy also blunted the low-pressure baroreceptor-mediated renal sympatho-inhibition. These findings demonstrate that in cardiac hypertrophy without impaired cardiac function, there is a blunted baroreceptor control of renal sympathetic outflow.


Subject(s)
Baroreflex/physiology , Cardiomegaly/physiopathology , Kidney/innervation , Sympathetic Nervous System/physiology , Unconscious, Psychology , Animals , Baroreflex/drug effects , Blood Pressure/drug effects , Body Weight/drug effects , Caffeine/pharmacology , Cardiomegaly/chemically induced , Central Nervous System Stimulants/pharmacology , Heart/drug effects , Heart Rate/drug effects , Isoproterenol/pharmacology , Male , Organ Size/drug effects , Pressoreceptors/drug effects , Pressoreceptors/physiology , Rats , Rats, Wistar , Sympathetic Nervous System/drug effects , Sympathomimetics/pharmacology , Thyroxine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL